The Novel Antioxidant Edaravone: From Bench to Bedside.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 2, p. 101, doi. 10.1111/j.1527-3466.2008.00041.x
- By:
- Publication type:
- Article
Works matching IS 17555914 AND DT 2008 AND VI 26 AND IP 2
Results: 8
1
2
Trimetazidine Revisited: A Comprehensive Review of the Pharmacological Effects and Analytical Techniques for the Determination of Trimetazidine.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 2, p. 147, doi. 10.1111/j.1527-3466.2008.00043.x
- By:
- Publication type:
- Article
3
Different Pharmacological Properties of Two Enantiomers in a Unique β-Blocker, Nebivolol.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 2, p. 115, doi. 10.1111/j.1527-3466.2008.00044.x
- By:
- Publication type:
- Article
4
Promoting Ethical Conduct in the Publication of Research.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
5
Clinical Effects of Torasemide Prolonged Release in Mild-to-Moderate Hypertension: A Randomized Noninferiority Trial Versus Torasemide Immediate Release.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 2, p. 91, doi. 10.1111/j.1527-3466.2008.00046.x
- By:
- Publication type:
- Article
6
Simvastatin: Two Decades in a Circle.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 2, p. 166, doi. 10.1111/j.1527-3466.2008.00047.x
- By:
- Publication type:
- Article
7
Viability of Developing CETP Inhibitors.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 2, p. 135, doi. 10.1111/j.1527-3466.2008.00049.x
- By:
- Publication type:
- Article
8
Biomarkers and Surrogate Endpoints in Cardiovascular Therapeutics Research: Under Scrutiny Following Results of the ENHANCE Study.
- Published in:
- 2008
- By:
- Publication type:
- Editorial